What we are clicking on

"Cell therapy makes up over 60% of the regenerative medicine market, most of which is in the area of stem cell therapy. Adult stem cells can be used in the areas of cardiology; musculoskeletal, including neurology; optometry; dermatology; cosmology; wound healing; and cancer. Stem cell therapy, when combined with immune and gene therapy, shows even greater potential to cure diseases. This new combination of regenerative cell therapies will open a new age of medicine, forever changing how it is practiced.”



“The newly published NEJM paper specifically reports that among all possible adverse cardiac events, heart attack risk went down most significantly, by 38 percent. There was also a 43 percent reduction in death from heart-related events for patients 50 and over who hit 120 mmHg.”



“There’s been a huge effort to ensure that fewer people are undertreated,” Dr. Sussman said. “Now, maybe we’ve crossed the line and too many people are overtreated.”



An objective assessment of health related apps, which are built using proprietary source code, have found serious flaws that have resulted in the dispensing of incorrect medical information and a disregard for patient privacy.



“Perhaps the most serious criticism of the consumer-focused strategy is that, no matter how well executed or widely adopted it is, it will do little to address the larger issue of rising health-care expenses. That’s because complex and chronic diseases drive the greatest share of costs, and providers still control most spending decisions where these illnesses are concerned.”



Your job as a physician is to create the ultimate experience for patients, from the minute they check into your office to the minute they’re discharged from the hospital. And that doesn’t just include fantastic medical care, it includes how they interact with the front desk staff, what the workflow is to get them into a room and to get them ready for surgery, and then how they’re treated post-operatively.”



 More than three million people in 19 states remain stuck in a “Medicaid gap,” too poor to qualify for subsidies in the new marketplaces, but unable to get into a government program.”